Rashomon revisited: two views of monitoring the Women's Health Initiative trials

Shapiro S. , Strax P. , Venet L. Evaluation of periodic breast cancer screening with mammography. Methodology and early observations. JAMA 1966; 195: 731—38.

The Coronary Drug Project Research Group. The Coronary Drug Project. Findings leading to discontinuation of the 2.5-mg/day estrogen group. JAMA 1973 ; 226: 652—7.

Prout TE , Knatterud GL , Meinert CL , Klimt CR The UGDP controversy. Clinical trials versus clinical impressions. Diabetes 1972; 21: 1035—40.

Echt DS , Liebson PR , Mitchell LB et al. Mortality and morbidity in patients receiving encainide, flecaininde, or placebo. The cardiac arrhythmia suppression trial. N Engl J Med 1991; 234: 781—88.

Anderson GL , Limacher M. , Assaf AR et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial . JAMA 2004; 291: 1701—12.

Rossouw JE , Anderson GL , Prentice RL et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 2002; 288: 321—33.

Anderson GL , Geller N. , Rossouw JE , Pettinger M. , Prentice RL Monitoring and reporting of the Women's Health Initiative randomized hormone therapy trials. Clinical Trials 2007; 4: 207—17,

Wittes J. , Barrett-Connor E. , Braunwald E. et al. Monitoring the randomized trials of the Women's Health Initiative: the experience of the data and safety monitoring board. Clinical Trials 2007; 4: 218—34.

Wittes J. Behind closed doors: the data monitoring board in randomized clinical trials . Stat Med 1993; 12: 419—24.

Coronary Drug Project Research Group. Practical aspects of decision making in clinical trials: The coronary drug project as a case study. Controlled Clinical Trials 1981; 1: 363—76.

Ellenberg SS , Fleming TR , DeMets DL Data monitoring committees in clinical trials: a practical perspective. Wiley, 2003.

DeMets DL , Furberg CD , Friedman LM Data monitoring in clinical trials: a case studies approach. Springer, 2005.

Grant AM , Altman DG , Babiker AB et al. Issues in data monitoring and interim analysis of trials. Health Technol Assess 2005; 9: 1—238.

Ashby D. , Tan SB Where's the utility in Bayesian data-monitoring of clinical trials? Clin Trials 2005; 2: 197—205; discussion 205—208.

Heitjan DF , Houts PS , Harvey HA A decision-theoretic evaluation of early stopping rules. Stat Med 1992; 11: 673—83.

Freedman L. , Anderson G. , Kipnis V. et al. Approaches to monitoring the results of long-term disease prevention trials: examples from the Women's Health Initiative . Control Clin Trials 1996; 17: 509—25.